|
|
|
|
Genome-wide Association Analysis to Evaluate Genetic Variations Associated with Rash Development in Telaprevir Phase 2 and 3 Studies
|
|
|
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
Jim C. Sullivan1, Darin Takemoto1, Jeroen Aerssens2, Kevin Kelliher1, Brian Hare1, Leif Bengtsson1, Raymond Rubin1, David Goldstein3, Martyn Botfield1
1Vertex Pharmaceuticals Incorporated, Cambridge, MA, USA; 2. Janssen Infectious Diseases BVBA, Beerse, Belgium; 3. Human Genome Research Institute, Duke University School of Medicine, Durham, NC, USA
|
|
|
|
|
|
|